Ara
Toplam kayıt 6, listelenen: 1-6
Effects of sympatholytic therapy with moxonidine on serum adiponectin levels in hypertensive women
(Sage Publications Ltd, 2008)
We examined whether moxonidine influences lipid profile, insulin resistance, adiponectin levels, renal function and microalbuminuria in women with essential hypertension in a study of SS non-diabetic hypertensive patients ...
Plasma lipocalin-2 levels in pregnancy
(Wiley-Blackwell, 2012)
Objective. To evaluate plasma levels of lipocalin-2, which is a novel adipokine associated with obesity and insulin resistance, in pregnant women. Design. Prospective casecontrol study. Setting. University hospital. ...
A new inflammatory marker in overweight patients: triggering receptor expressed on myeloid cells-1
(COMENIUS UNIV, 2020)
BACKGROUND: Triggering receptor expressed on myeloid cells 1 (TREM-1) is secreted by phagocytes in adipose tissue and it also upregulates the expression of genes involved in the inflammatory response and atherosclerotic ...
The effect of insulin resistance on mortality in critically ill patients in the intensive care unit
(INDIAN ANAESTHETISTS FORUM, 2020)
Background and Aims: Insulin resistance can be described as a subnormal biological response to a specific insulin concentration or deterioration of an accepted response to insulin in glucose homeostasis and deficiency of ...
Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome
(Oxford Univ Press, 2005)
BACKGROUND: The aim of the present study was to evaluate insulin resistance (IR), glucose tolerance status and cardiovascular risk factors in first degree relatives of patients with polycystic ovary syndrome (PCOS). METHODS: ...
The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome
(Oxford Univ Press, 2005)
BACKGOUND: Oxidative stress and hyperhomocysteinaemia are risk factors for cardiovascular diseases. The aim of this study was to assess the effects of rosiglitazone and metformin on cardiovascular disease risk factors such ...